Ann Intern Med
Can thread embedding help women lose weight?

Clinical takeaway: Acupoint thread embedding produced modest additional weight loss in reproductive-age women receiving lifestyle education, but cardiometabolic benefits were not demonstrated. Clinicians counseling interested patients should emphasize the limited evidence on long-term efficacy and uncommon harms.
Obesity affects nearly 3 billion adults worldwide and remains difficult to manage long term because adherence to lifestyle interventions is often poor. Although GLP-1–based therapies have expanded treatment options, cost, tolerability, pregnancy-related considerations, and access barriers leave many patients seeking nonpharmacologic alternatives.
Acupoint thread embedding (ATE) places absorbable surgical thread at acupuncture points to prolong stimulation. It could offer an adjunct for patients seeking nonpharmacologic weight-management options, but rigorous evidence has been limited.
In the WOVEN trial, women receiving ATE lost an additional 1.8 kg compared with sham treatment after 12 weeks and an additional 3.0 kg by week 24, suggesting the effect persisted after the intervention period ended. BMI declined by an additional 0.7 kg/m² at 12 weeks and 1.1 kg/m² at 24 weeks versus sham treatment.
Clinically meaningful weight loss was more common with ATE. At week 12, 25.8% of participants receiving ATE achieved at least 5% weight loss versus 9.1% in the sham group; by week 24, those rates increased to 31.8% and 10.6%, respectively. ATE also produced greater reductions in waist circumference, hip circumference, body fat percentage, and appetite scores, but cardiometabolic markers, liver-related measures, quality-of-life scores, and anxiety scores were similar between groups.
Researchers randomly assigned 132 Chinese women aged 18 to 45 years with overweight or obesity to ATE or sham ATE. Participants received six treatment sessions over 12 weeks plus lifestyle counseling, followed by a 12-week observation period; the primary outcome was change in BMI at week 12.
The findings suggest ATE may have a role as an adjunctive weight-management strategy rather than a replacement for established therapies. Given the modest effect size and limited study population, clinicians should view the intervention as a complementary option pending larger and more diverse trials.
The authors noted that appetite suppression may be one possible mechanism, as appetite scores improved more with ATE, but emphasized that the biologic pathways remain speculative and require further study. Future trials are planned to include more diverse populations, longer follow-up, mechanistic assessments, and direct comparisons with lifestyle and pharmacologic therapies.
“Acupoint thread embedding may offer an intermittently delivered option with a favorable short-term safety profile, particularly for women of reproductive age, when lifestyle interventions are difficult to sustain or pharmacotherapy is inaccessible, poorly tolerated, or contraindicated,” wrote the authors.
Source: Xu S, et al. (2026 Nov 17) Ann Intern Med. Acupoint Thread Embedding for Weight Loss in Women With Overweight or Obesity